Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Herbert Patterson

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Current Cardiology Reviews|November 21, 2013
Evolution of biomarker guided therapy for heart failure: current concepts and trial evidenceAmanda E Pruett, Amanda K Lee, J Herbert Patterson, et al.
American Heart Journal|June 2, 2007
Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fractionFrançois Alla, Ahmad Y Al-Hindi, Craig R Lee, et al.
Pharmacotherapy|November 12, 2013
Acute decompensated heart failure: evolving literature and implications for future practiceJonathan D Cicci, Brent N Reed, Elizabeth B McNeely, et al.
American Journal of Pharmaceutical Education|July 20, 2021
Qualitative Evaluation of a Junior Faculty Team Mentoring ProgramLana M Minshew, Jacqueline M Zeeman, Amanda A Olsen, et al.
Frontiers in Pharmacology|May 12, 2020
Precision Dosing Priority Criteria: Drug, Disease, and Patient Population VariablesRachel J Tyson, Christine C Park, J Robert Powell, et al.
American Heart Journal|July 10, 2003
Vasopressin: a new target for the treatment of heart failureCraig R Lee, Michael L Watkins, J Herbert Patterson, et al.
Journal of the American College of Cardiology|August 2, 2005
Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysisKirkwood F Adams, J Herbert Patterson, Wendy A Gattis, et al.
Clinical and Translational Science|April 9, 2020
Rivaroxaban Precision Dosing Strategy for Real-World Atrial Fibrillation PatientsRobyn Konicki, Daniel Weiner, J Herbert Patterson, et al.
Circulation. Heart Failure|May 18, 2011
Modulation of novel cardiorenal and inflammatory biomarkers by intravenous nitroglycerin and nesiritide in acute decompensated heart failure: an exploratory studySheryl L Chow, Stephen A O'Barr, Jessica Peng, et al.
Journal of Cardiac Failure|March 3, 2011
Renal function and neurohormonal changes following intravenous infusions of nitroglycerin versus nesiritide in patients with acute decompensated heart failureSheryl L Chow, Stephen A O'Barr, Jessica Peng, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Current Cardiology Reviews|November 21, 2013
Evolution of biomarker guided therapy for heart failure: current concepts and trial evidenceAmanda E Pruett, Amanda K Lee, J Herbert Patterson, et al.
American Heart Journal|June 2, 2007
Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fractionFrançois Alla, Ahmad Y Al-Hindi, Craig R Lee, et al.
Pharmacotherapy|November 12, 2013
Acute decompensated heart failure: evolving literature and implications for future practiceJonathan D Cicci, Brent N Reed, Elizabeth B McNeely, et al.
American Journal of Pharmaceutical Education|July 20, 2021
Qualitative Evaluation of a Junior Faculty Team Mentoring ProgramLana M Minshew, Jacqueline M Zeeman, Amanda A Olsen, et al.
Frontiers in Pharmacology|May 12, 2020
Precision Dosing Priority Criteria: Drug, Disease, and Patient Population VariablesRachel J Tyson, Christine C Park, J Robert Powell, et al.
American Heart Journal|July 10, 2003
Vasopressin: a new target for the treatment of heart failureCraig R Lee, Michael L Watkins, J Herbert Patterson, et al.
Journal of the American College of Cardiology|August 2, 2005
Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysisKirkwood F Adams, J Herbert Patterson, Wendy A Gattis, et al.
Clinical and Translational Science|April 9, 2020
Rivaroxaban Precision Dosing Strategy for Real-World Atrial Fibrillation PatientsRobyn Konicki, Daniel Weiner, J Herbert Patterson, et al.
Circulation. Heart Failure|May 18, 2011
Modulation of novel cardiorenal and inflammatory biomarkers by intravenous nitroglycerin and nesiritide in acute decompensated heart failure: an exploratory studySheryl L Chow, Stephen A O'Barr, Jessica Peng, et al.
Journal of Cardiac Failure|March 3, 2011
Renal function and neurohormonal changes following intravenous infusions of nitroglycerin versus nesiritide in patients with acute decompensated heart failureSheryl L Chow, Stephen A O'Barr, Jessica Peng, et al.
Pageof 7